We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
+2.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$297M
AUM Growth
+$56.9M
(+24%)
Cap. Flow
+$55.4M
Cap. Flow
% of AUM
18.67%
Top 10 Holdings %
Top 10 Hldgs %
80.3%
Holding
232
New
27
Increased
80
Reduced
67
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$25.2M |
| 2 |
Invitation Homes
INVH
|
+$6.9M |
| 3 |
American Homes 4 Rent
AMH
|
+$3.4M |
| 4 |
LAZR
Luminar Technologies
LAZR
|
+$1.51M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$1.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$978K |
| 2 |
Omnicell
OMCL
|
+$641K |
| 3 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
+$568K |
| 4 |
RAVN
Raven Industries Inc
RAVN
|
+$373K |
| 5 |
NNDM
Nano Dimension
NNDM
|
+$287K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 18.29% |
| 2 | Healthcare | 13.15% |
| 3 | Technology | 2% |
| 4 | Industrials | 1.37% |
| 5 | Consumer Discretionary | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MBS ETF
MBB
$39.3B
| $106M | 35.83% |
980,000
+230,000
| +31% | +$25.2M |
|
2
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
| $68M | 22.95% |
1,275,000
| – | – |
|
|
3
Invitation Homes
INVH
$17.9B
| $27.3M | 9.21% |
854,144
+230,000
| +37% | +$6.9M |
|
|
4
American Homes 4 Rent
AMH
$12.3B
| $26.9M | 9.07% |
806,924
+109,000
| +16% | +$3.4M |
|
5
Stereotaxis
STXS
$154M
| $2.18M | 0.74% |
325,000
| – | – |
|
6
Azenta
AZTA
$1.21B
| $1.63M | 0.55% |
20,000
| – | – |
|
|
RAVN
7
DELISTED
Raven Industries Inc
RAVN
| $1.53M | 0.52% |
40,000
-10,000
| -20% | -$373K |
|
8
Intuitive Surgical
ISRG
$122B
| $1.48M | 0.5% |
6,000
| – | – |
|
9
AeroVironment
AVAV
$7.2B
| $1.45M | 0.49% |
12,500
| – | – |
|
10
Regeneron Pharmaceuticals
REGN
$70.9B
| $1.32M | 0.45% |
2,800
+1,500
| +115% | +$730K |
|
|
LKFT
11
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.97B
| $1.31M | 0.44% |
17,000
+14,600
| +608% | +$1.34M |
|
|
12
Omnicell
OMCL
$2.09B
| $1.3M | 0.44% |
10,000
-5,000
| -33% | -$641K |
|
13
Allient
ALNT
$1.49B
| $1.28M | 0.43% |
37,500
| – | – |
|
14
Ametek
AME
$54.3B
| $1.28M | 0.43% |
10,000
| – | – |
|
15
Synopsys
SNPS
$73.6B
| $1.24M | 0.42% |
5,000
| – | – |
|
|
LAZR
16
DELISTED
Luminar Technologies
LAZR
| $1.22M | 0.41% |
+3,333
| New | +$1.51M |
|
|
BLUE
17
DELISTED
bluebird bio
BLUE
| $1.13M | 0.38% |
2,895
+2,185
| +308% | +$1.08M |
|
18
Merck
MRK
$315B
| $1.12M | 0.38% |
15,196
+12,890
| +559% | +$951K |
|
19
Accuray
ARAY
$30.8M
| $1.11M | 0.38% |
225,000
+75,000
| +50% | +$387K |
|
20
uniQure
QURE
$2.77B
| $1.09M | 0.37% |
32,500
+27,500
| +550% | +$986K |
|
|
NUAN
21
DELISTED
Nuance Communications, Inc.
NUAN
| $1.09M | 0.37% |
25,000
-5,000
| -17% | -$230K |
|
22
BioXcel Therapeutics
BTAI
$27.4M
| $1.08M | 0.36% |
1,563
| – | – |
|
23
ClearPoint Neuro
CLPT
$454M
| $1.06M | 0.36% |
+50,000
| New | +$1.07M |
|
24
Novanta
NOVT
$5.3B
| $989K | 0.33% |
7,500
| – | – |
|
25
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
| $875K | 0.3% |
10,149
+2,101
| +26% | +$181K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, AlphaCentric Advisors held 232 positions worth $297M, up 24% from $240M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
AlphaCentric Advisors deployed $55.4M of net new capital in Q1 2021, opening 27 new positions and adding to 80 existing holdings. Its largest new stake was Luminar Technologies: 3,333 shares worth $1.22M.
By sector, the portfolio is most concentrated in Real Estate at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Omnicell, an estimated $641K trimmed.
- AlphaCentric Advisors's largest Q1 2021 buy was Luminar Technologies: 3,333 shares worth $1.22M.
- AlphaCentric Advisors added most to iShares MBS ETF in Q1 2021, an estimated $25.2M increase.
- AlphaCentric Advisors's biggest Q1 2021 reduction was Omnicell, cutting an estimated $641K.
- AlphaCentric Advisors fully exited Globus Medical in Q1 2021, selling an estimated $978K.
- AlphaCentric Advisors's ten largest holdings make up 80% of its $297M portfolio in Q1 2021.
- AlphaCentric Advisors opened 27 new positions and closed 26 in Q1 2021.
- AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $297M.
Based on AlphaCentric Advisors's 13F filing for Q1 2021, filed 9 Mar 2022.